This video is our Medical Director explaining the program basics For information regarding Belviq and Qsymia – Click Here For information concerning Contrave and Saxenda Click Here
Southampton Health Services Guidelines to Weight Management
Obesity is one of the most common medical problems in the United States and itincreases the risk for many other illnesses such as diabetes, hypertension, atherosclerosis(hardening of the arteries), heart disease, strokes, kidney failure, and breast, endometrial,gallbladder, kidney and colon cancer. “Obesity should not be considered a characterweakness, and should not be thought of as a result of being out of control.” (Blackburn,Advanced Studies in Medicine-Johns Hopkins, 1/2002). Rather, it should be treated as achronic disease like hypertension and diabetes for which long-term drug treatment mayneed to be continued “for years an perhaps a lifetime to improve health and maintain ahealthy weight.” (NIHPub #97-419], 12/1996)
Benefits of Weight Loss
Innumerable medical studies have now shown that weight reduction in obese patients andoverweight patients with increased comorbid risks provides significant medical benefit.In 1996, in attempt to thwart our nation’s obesity epidemic, The National Institutes ofHealth and Surgeon General C. Everett Koop, M.D. in the Shape Up America programproposal stated, “Comorbid conditions increase the risk of disability or prematuremortality” (subsequently., obesity has been shown to decrease life expectancy by morethan four years).
The National Institutes of Health delineated comorbid conditions as:
- Hypertension-Cardiovascular disease
- Dyslipidemia-Type 1 or 2 diabetes
- Obstructive sleep apnea
- Female infertility
- Lower extremity venous stasis disease
- Gastroesophageal reflux disease
- Urinary stress incontinence, and
- Idiopathic intracranial hypertension.
It also stated “An increased risk for all cause mortality has been shown for BMI >27.”
Lifestyle modification through diet, exercise, and changes in behaviors associated witheating is essential to lose and then to maintain weight loss. Although a 5 -10% weightloss may be perceived by a patient as insignificant, such success should be praised as itimproves many obesity-related conditions.
At Southampton Health Services, our goal is to assist our patients in the long-termmanagement of their weight. We continually stress and reinforce a cardiovascularexercise program (for example, walking for 1/2 -3/4 hrs six days per week) and prescribe a diet that is low in simple sugars with reduced saturated fats and carbohydrates. Eatingwithin two hours of going to bed (hibernation) must be stopped. Fast foods, fried foods,all-you-can-eat buffets, high-density/high calorie sit down restaurants, sweet-teas, sodas,bottled juices, and other sugar/carbohydrate snacks need to be eliminated. Alcohol,because of both calories and potential interactions with medications, is not allowed.
“Because obesity is a chronic condition, pharmacotherapy should be initiated with theexpectation that long-term use will most likely be needed” (National Task Force on thePrevention and Treatment of Obesity. JAMA, 1996). Use of anorectic medications assistin weight loss while providing reinforcement that lifestyle modifications are effective.
Use of Diuretics
Since many of our patients have increased total body salt-water due to a number offactors including body habitus and high salt intake, we frequently will prescribe adiuretic. We most commonly prescribe Maxzide, a potassium-sparing diuretic. If this isprescribed, periodic monitoring of both blood sugar and potassium levels is necessary asdiuretics can cause both increased blood sugar and decreased potassium. It is the policyat SHS to test these blood levels every ten weeks. If the patient does not get these tested,the diuretic cannot be prescribed (the appetite suppressant can be prescribed).